No Data
No Data
Roivant Sciences' (NASDAQ:ROIV) Performance Raises Some Questions
Even though Roivant Sciences Ltd. (NASDAQ:ROIV) posted strong earnings recently, the stock hasn't reacted in a large way. We decided to have a deeper look, and we believe that investors might be worr
Buy Rating Justified by Roivant Sciences' Growth Prospects and Strategic Pipeline Expansion
The Analyst Verdict: Roivant Sciences In The Eyes Of 6 Experts
6 analysts have shared their evaluations of Roivant Sciences (NASDAQ:ROIV) during the recent three months, expressing a mix of bullish and bearish perspectives.Summarizing their recent assessments, th
Piper Sandler Keeps Their Buy Rating on Roivant Sciences (ROIV)
Express News | HC Wainwright & Co. Reiterates Buy on Roivant Sciences, Maintains $18 Price Target
Roivant Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/31/2024 71.43% HC Wainwright & Co. $18 → $18 Reiterates Buy → Buy 04/22/2024 71.43% HC Wainwright & Co.